Sir,

We thank the reader for the interest and putting forward their opinion on our article published in Indian Dermatology Online Journal.\[[@ref1][@ref2]\]

Our patient, a 30-year-old female presented to us with nodular erythematous infiltration of the skin \[Figure [1a](#F1){ref-type="fig"}--[c](#F1){ref-type="fig"}\] and was diagnosed with acute lymphoblastic leukemia with cutaneous infiltration after thorough work up. The skin biopsy revealed a B-cell type lymphoblastic infiltrate \[[Figure 2](#F2){ref-type="fig"}, arrows\], and inmunohistochemistry was positive for TdT \[[Figure 3](#F3){ref-type="fig"}\], PAX-5, CD5, CD3, and negative for CD20 and CD1a. A bone marrow aspirate was performed and showed 80% blast cells with L1 type morphology \[[Figure 4](#F4){ref-type="fig"}\]. In addition, flow cytometry was positive for CD10, CD13, CD15, and negative for CD20.

![(a) Multiple infiltrated erythematous nodules on the patient\'s face. (b) Erythematous nodules on the patient\'s right cheek. (c) The patient\'s right earlobe with an erythematous infiltrated aspect](IDOJ-7-135-g001){#F1}

![Skin biopsy stained with H and E, ×10. Periadnexal and deep dermal B-cell type lymphoblastic infiltrate](IDOJ-7-135-g002){#F2}

![Skin biopsy, TdT immunofluorescence, ×10. Diffuse and strong, finely granular pattern, uniformly distributed in the nucleus](IDOJ-7-135-g003){#F3}

![Bone marrow aspirate. Hypercellular bone marrow, with decreased megakaryocytes and replaced with 90% lymphoblasts](IDOJ-7-135-g004){#F4}

The patient was then referred to the hematologist and was treated with systemic chemotherapy (remission--induction, consolidation and maintenance) consisting of vinca alkaloids, anthracyclines, and corticosteroids. She presented complete clearance of the cutaneous lesions after a 6-month follow-up \[[Figure 5](#F5){ref-type="fig"}\]. We did not include the details of the bone marrow aspirate in our article as it may take away the suspense of the quiz as suggested by the reviewers and editors.

![The patient\'s right cheek and earlobe 6 months after starting chemotherapy](IDOJ-7-135-g005){#F5}
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